Ricevi le ultime notizie sulle azioni Akari Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di AKTX

Ultime notizie per

Akari Therapeutics

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics PLC

Abpro Hldgs

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

BioCardia

BriaCell Therapeutics Corp. - Common Shares

BriaCell Therapeutics

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Curis

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Edesa Biotech

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech

FibroBiologics

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Geovax Labs

Kairos Pharma

Longeveron

Lunai Bioworks

Lisata Therapeutics

MetaVia

NeuroSense Therapeutics Ltd. - Ordinary Shares

NeuroSense Therapeutics

OSR Holdings

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics

Synlogic

Exicure

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty

Akari Therapeutics (AKTX) Previsione

Notizie

Utili

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

Comments

Akari Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO